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Microarray analysis of host cell gene expression during an adenovirus type 2 infection showed that the number of regulated genes, as well as
the magnitude of change, was increased as the infection proceeded into the late phase. In contrast to the early phase of infection when the majority
of differentially expressed genes were upregulated, expression of most of the regulated genes (82 out of 112) declined during the late phase. In
particular, numerous TGF-h inducible genes and several TGF-h-independent growth-arrest-inducing genes were targeted. Of the 30 genes
upregulated more than 2-fold at 20 h post-infection, nearly two-thirds of encoded proteins are involved in cell metabolism. The data indicate that
adenovirus primarily targets cellular genes involved in antiviral defense, cell growth arrest and apoptosis, as well as cell metabolism, to ensure
sufficient production of viral progeny.
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To obtain efficient production of progeny virus, human
adenovirus must ensure high expression of its genes, induce
favorable conditions for viral DNA replication and counteract
the host cell antiviral defense. Parts of these goals are achieved
by modifying the transcriptional machinery of the infected cell.
Activation of the adenovirus early genes is primarily achieved
through interaction between the conserved region 3 (CR3) of
the immediate adenovirus E1A protein and the Sur2 subunit of
the Mediator complex (Wang and Berk, 2002), probably
increasing the efficiency of RNA polymerase II recruitment
to viral promoters. Induction of the S-phase, on the other hand,
is mainly ascribed to the ability of E1A to bind members of
retinoblastoma tumor suppressor (pRb) family. By binding to
pRb, E1A will alleviate the inhibitory pRb–E2F interaction,
thereby activating expression of E2F-dependent genes (Cobri-
nik, 1996). Although this has been proposed to cause a
significant deregulation of host cell E2F-dependent genes
(Zhao et al., 2003), the transcription factor E2F is also required0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(Kovesdi et al., 1986). In addition, the E4 orf6/7 further
activates E2 expression by stabilizing the interaction of E2F to
the duplicated E2F binding sites in the E2 promoter used
specifically during the early phase of infection (Bagchi et al.,
1990; Neill et al., 1990). E1A also targets the transcriptional
coactivators p300/CBP, which have been implicated in multiple
cellular processes by interacting with a growing list of
transcription factors (Arany et al., 1995; Bannister and
Kouzarides, 1995). As coactivators, p300/CBP act not only
as transcriptional integrators creating architectural scaffolds for
transcription complex assembly, but also as chromatin modi-
fiers through their intrinsic acetyl transferase activities (Chan
and La Thangue, 2001). Although the ability of E1A to bind
and sequester p300/CBP has been described as one of the
major explanations for transcriptional repression by E1A,
mainly leading to the induction of cell proliferation (Arany et
al., 1995; Bannister and Kouzarides, 1995), E1A may also
redirect p300/CBP to activate specific target genes (Fax et al.,
2000). Additional possibilities for E1A to deregulate cellular
transcription are given by the ability of E1A to bind to p400/
TRRAP containing chromatin-remodeling complexes (Deleu et
al., 2001; Fuchs et al., 2001; Lang and Hearing, 2003;5) 236 – 245
www.e
F. Granberg et al. / Virology 343 (2005) 236–245 237Nikiforov et al., 2002) and to the corepressor C-terminal
Binding Protein (CtBP) (Chinnadurai, 2004; Johansson et al.,
2005). Thus, the ability of E1A to target different cellular
proteins involved in transcriptional regulation offers a variety
of possibilities to modulate the host cell growth controlling
activities.
Furthermore, adenovirus early genes also target the cellular
p53 tumor suppressor protein which blocks cell cycle
progression. In addition to the direct binding to p53, thereby
blocking p53-dependent transcriptional activation (Sarnow et
al., 1982; Yew et al., 1994), E1B-55 kDa protein also forms
complex with E4 open reading frame 6 (E4orf6) protein and
mediates the ubiquitylation and degradation of p53 (Querido et
al., 2001; Steegenga et al., 1998).
As described, most of the direct effects on host cell gene
expression during the early phase are due to E1A. Since the
p300/CBP coactivators act on transcription factors controlling
genes involved in antiviral defense, it is conceivable that E1A
directly deregulates these genes. However, the ability of
adenovirus to interfere with the host antiviral response also
involves the capacity of adenovirus E3 proteins to interrupt
antigen presentation and pro-inflammatory signaling (Wold et
al., 1994). The E3-gp19K prevents exposure of viral peptides
on the cell surface by inhibiting the transport of class I major
histocompatibility complex from the ER to the plasma
membrane as well as inhibiting the loading of peptide by
tapasin (Bennett et al., 1999; Burgert et al., 1987; Wold et al.,
1999). The E3-10.4 K and 14.5 K (RIDa/h) complex prevents
tumor necrosis factor alpha (TNFa) and Fas ligand-induced
cell death by destroying the death domain-containing receptors
through internalization and, subsequently, degradation in the
lysosome. In addition, the E3-10.4 K/14.5 K complex also
blocks the activation of NF-nB by preventing NF-nB from
entering the nucleus and by inhibiting the activity of the kinase
complex IKK (Friedman and Horwitz, 2002). Since the
transcription factor NF-nB promotes the expression of several
hundred target genes, mainly involved in the host immune
response (Ghosh et al., 1998), it is anticipated that the
inhibition of the NF-nB pathway leads to deregulated
expression of many target genes during the adenovirus
infection.
After the onset of adenovirus DNA replication, viral
transcription switches from the early regions to late regions.
Although progression of adenovirus infection results in
inhibition of cellular DNA replication and protein synthesis
(Hodge and Scharff, 1969; Huang and Schneider, 1991; Pina
and Green, 1969), minor effects have been observed on the
transcription of cellular genes (Beltz and Flint, 1979).
However, the export of newly synthesized cellular mRNA
from the nucleus to the cytoplasm is dramatically reduced
during the viral late phase (Beltz and Flint, 1979). In contrast,
viral RNAs are efficiently transported to the cytoplasm (Pilder
et al., 1986). The E1B-55 kDa/E4-34 kDa protein complex has
been shown to be required both for blocking cellular mRNA
transport and facilitating export of viral mRNAs late after
infection (Bridge and Ketner, 1990; Corbin-Lickfett and
Bridge, 2003; Sarnow et al., 1984). In addition, viral mRNAsare preferentially translated after reaching the cytoplasm.
Expression of the L4-100 kDa protein from the major late
transcription unit has been implicated in regulation of viral
gene expression and turning off expression of cellular genes
(Farley et al., 2004; Hayes et al., 1990; Cuesta et al., 2000).
The knowledge about the regulation of host cell gene
expression at the transcriptional level during adenovirus
infection is limited. Microarray technology has proved to be
a powerful tool to monitor changes in the expression of
thousands of host cell genes in response to infectious
pathogens. Our previous studies have focused on the host cell
gene expression during the early phase of adenovirus infection.
We showed that adenovirus modulates expression of a limited
set of cellular genes at 6 h post-infection of HeLa cells. Here,
we have extended our study to the late phase of the infection
and describe virus-induced changes in gene expression at 10
and 20 h post-infection.
Results
Augmented regulation of host gene expression during
progression of an adenovirus infection
Using cDNA microarray analysis, we have previously
studied adenovirus type 2-induced modification of host cell
gene expression at early time (6 h) of infection (Zhao et al.,
2003). In this study, we measured cellular gene expression as
the virus infection proceeded into the late phase. Quantification
of viral gene expression using the adenovirus amplicons
present on the microarray showed that adenovirus early genes
were expressed to high levels at 10 h post-infection, whereas
expression of the late genes, L1 and L3, was still very low (data
not shown). At 20 h post-infection, the expression levels of
both early genes and late genes increased dramatically.
Coordinately, the number of differentially expressed host cell
genes, as well as the magnitude of regulation, was significantly
increased. A similar increase was also seen when comparing
differentially expressed host cell genes between 6 and 10
h post-infection. In our previous study, we identified 76 genes
showing more than 1.5-fold changes using three different
cDNA arrays containing totally 12,309 unique genes. Sixteen
of these genes were identified on the 7500 cDNA array used in
the present investigation. Notably, using the same 1.5-fold
threshold, 60 and 382 genes were found to be differentially
regulated at 10 and 20 h post-infection, respectively. Therefore,
we concluded that the regulation of host cell gene expression
was augmented as the virus infection progressed into the late
phase.
The genes that were differentially regulated throughout the
early and late phases of adenovirus infection are shown in
Table 1. For most of these genes, the expression patterns were
maintained during the early to late transition, although a
slightly increased level of regulation during the late phase was
observed. However, three transcription factors, JUNB, NR4A1
and ZNF503, that were upregulated at 6 h post-infection were
downregulated during the late phase of infection. In contrast,
expression of SSB, encoding the autoantigen La, showed a
Table 1
Genes differentially expressed during the progression of an adenovirus infection
Clone ID Symbol 6 ha 10 h 20 h Gene name
50615 HSPA1L 2.0b 4.7 3.5 Heat shock 70 kDa protein 1-like
486678 P2RX5 1.5 1.2 1.8 Purinergic receptor P2X
49970 SSB 2.3 1.2 1.7 Sjogren syndrome antigen B (autoantigen La)
810457 RNPC1 1.8 1.5 1.5 RNA-binding region (RNP1, RRM) containing 1
204301 CDC25A 1.7 1.8 1.3 Cell division cycle 25A
310406 IL6 1.7 2.0 1.4 Interleukin 6 (interferon, beta 2)
1928791 F3 2.4 1.2 1.5 Coagulation factor III
309893 NR4A1 2.1 1.1 1.5 Nuclear receptor subfamily 4, group A, member 1
810457 ZNF503c 2.3 1.1 1.5 Zinc finger protein 503
770670 TNFAIP3 1.8 1.9 1.9 Tumor necrosis factor, alpha-induced protein 3
309864 JUNB 2.1 1.2 2.5 Jun B proto-oncogene
365826 GAS1 1.8 2.1 2.7 Growth arrest-specific 1
756405 ID3 1.5 2.4 4.1 Inhibitor of DNA binding 3, dominant negative
helix– loop–helix protein
795877 PLK2c 1.5 2.7 4.3 Polo-like kinase 2 (Drosophila)
812965 MYC 1.5d 1.9 7.4 V-myc myelocytomatosis viral oncogene homolog (avian)
232946 SGK 1.7 3.5 8.2 Serum/glucocorticoid regulated kinase
a Data for 6 h were from previous study (Zhao et al., 2003), using average values obtained from three different arrays.
b Fold change in expression between RNA from infected cells compared to RNA from uninfected cells.
c PLK2 was named SNK, and ZNF503 was given as MGC2555 in Zhao et al. (2003).
d Data obtained from QRT-PCR.
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the late phase. Finally, upregulation of CDC25A, a known E1A
target (Spitkovsky et al., 1996), was sustained up to 10 h post-
infection but diminished at 20 h post-infection.
In addition to an increased number of genes regulated at 10
and 20 h post-infection, we also observed that the average
magnitude of regulation increased with the infection time.
Thus, the 112 genes showing at least a 2-fold change in
expression levels in at least one of the two analyzed time points
were identified as specifically regulated during the late phase of
infection. It should be noted that approximately 2160 of the
genes printed on the array were detectably expressed in mock-
infected cells. Using information extracted mainly from
SOURCE (database from Genetics Department, Stanford
University) and PubMed, known or suggested functions were
used to classify 101 identified genes into four categories (listed
in Tables 2a–2d). Eleven genes, for which definite functions
were unavailable, were excluded. Generally, in contrast to gene
regulation during the early phase of infection when a majority
of the differentially expressed genes were activated, most genes
(82 of the 112) identified in this study were downregulated at
20 h post-infection.
Adenovirus regulation of host cell genes controlling cell cycle
and proliferation is consistent with targeting of growth
inhibitory activities
Twenty-four genes, classified as regulators of cell cycle and
proliferation, were identified as differentially expressed (Table
2a). Several genes encoding transcription factors, including
JUNB, ID3, TGFB1I4, KLF4, KLF10, MYC and ETS2, were
repressed. The transcription factor ETS2 inhibits the cell cycle
through activation of the cdk kinase inhibitor p16 (Ohtani et
al., 2001). Consistent with earlier microarray experiments, we
found that expression of MYC was persistently downregulatedthroughout the lytic cycle (Lohr et al., 2003; Zhao et al., 2003).
Expression of additional genes related to growth arrest, such
as GAS1, TOB1 and ELL2, and inhibition of cell cycle
progression ARHE (Villalonga et al., 2004) and were also
downregulated. Only two genes, encoding the transcription
factors AATF and MYBL2, were upregulated. Interestingly,
AATF has a positive effect on growth by relieving the
inhibitory effect of Rb on E2F (Fanciulli et al., 2000) and
blocking Dlk/ZIP-kinase-induced apoptosis (Page et al., 1999),
whereas MTBL2 plays a stimulatory role in cell cycle
progression (Manak et al., 2002). The most dramatically
downregulated gene in this group was SGK encoding a
serine/threonine protein kinase, which is a potent regulator of
various ion channels and has diverse functions including cell
proliferation and apoptosis (Lang et al., 2003).
Sustained downregulation of genes involved in antiviral
defense and stress response
Similar to the early phase of infection, all of the
differentially regulated genes classified as being involved in
the antiviral and stress responses were downregulated (Table
2b). As a central mediator of the immune response, the NF-nB
pathway has been described as a primary target for many
viruses, including adenovirus. Two of its key players, NFKB2
(p50) and NFKBIA (InBa), were downregulated. Although
NFKBIA is the inhibitor of NFKB, its expression is also
controlled by NF-nB. Within this group, we also identified IL-
6, the IL-6-induced transcription factor CEBPB and the
hypoxia susceptibility transcription factor NFE2L2 (Akira et
al., 1990; Chan et al., 2001). Furthermore, LITAF, an important
regulator of tumor necrosis factor alpha (TNFa) gene
expression, was targeted (Myokai et al., 1999). Correspond-
ingly, the TNFa-induced genes IER3 (Table 2b) and TNFAIP3
(Table 1) were found to be downregulated. Finally, transcript
Table 2a
Differentially expressed genes involved in cell cycle and proliferation
Clone ID Symbol 10 h 20 h Name
842973 PA2G4 1.3a 2.3 Proliferation-associated 2G4, 38 kDa
815526 MYBL2 1.3 2.2 V-myb myeloblastosis viral oncogene homolog (avian)-like 2
845363 NME1 1.0 2.2 Non-metastatic cells 1, protein (NM23A) expressed in
2072912 AATF 1.3 2.0 Apoptosis antagonizing transcription factor
266106 YWHAE 1.1 2.0 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, epsilon polypeptide
214133 BRD2 2.1 1.2 Bromodomain containing 2
188232 KLF4 1.2 2.0 Kruppel-like factor 4
725454 CKS2 1.1 2.1 CDC28 protein kinase regulatory subunit 2
489282 KLF10 1.5 2.2 Kruppel-like factor 10
823940 TOB1 1.3 2.2 Transducer of ERBB2, 1
811848 TGFB1I1 1.7 2.3 Transforming growth factor beta 1 induced transcript 1
309864 JUNB 1.2 2.5 Jun B proto-oncogene
260303 ETS2 1.6 2.5 V-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
365826 GAS1 2.1 2.7 Growth arrest-specific 1
784593 ARHE 1.5 2.8 Ras homolog gene family, member E
898092 CTGF 1.2 3.1 Connective tissue growth factor
626716 ELL2 1.7 3.5 Elongation factor, RNA polymerase II, 2
756405 ID3 2.4 4.1 Inhibitor of DNA binding 3, dominant negative helix– loop–helix protein
795877 PLK2 2.7 4.3 Polo-like kinase 2 (Drosophila)
504527 DUSP1 1.4 4.4 Dual specificity phosphatase 1
868630 TGFB1I4 2.0 4.8 Transforming growth factor beta 1 induced transcript 4
812965 MYC 1.9 7.4 V-myc myelocytomatosis viral oncogene homolog (avian)
840776 SGK 3.5 8.2 Serum/glucocorticoid regulated kinase
a As described in Table 1.
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decreased, including MAP2K3, metallothioneins MT1E and
1H and transcription factor HIF1A.
Deregulation of genes controlling cell architecture and
communication
A notable category of genes targeted during the late phase of
infection was related to cell structure, communication andTable 2b
Differentially expressed genes involved in immune and stress response


















a As described in Table 1.transport (Table 2c). Several genes controlling cytoskeleton
organization were downregulated, including ARPC5, a subunit
of Arp2/3 complex that nucleates actin filament polymeriza-
tion, and TMOD3, which caps the pointed ends of thin actin
filament. Intermediate filament was also targeted as indicated
by reduced levels of transcripts of the cytokeratin KRT19. In
addition to direct effects on cell structure components, several
genes linking structure to signaling pathways were deregulated
including LMO7, PDLIM7 and VIL2 that act as mediators20 h Name
7.2 Trophoblast-derived noncoding RNA
4.0 Hypoxia-inducible factor 1, alpha subunit
(basic helix– loop–helix transcription factor)
4.0 Chemokine orphan receptor 1
3.2 Nuclear factor (erythroid-derived 2)-like 2
3.0 Immediate early response 3
2.9 Chemokine (C-X-C motif) receptor 4
2.9 Decay accelerating factor for complement
2.8 Annexin A1
2.7 Metallothionein 1E (functional)
2.5 Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 2 (p49/p100)
2.5 Cardiotrophin 1
2.4 CCAAT/enhancer binding protein (C/EBP), beta
2.4 Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha
2.3 Mitogen-activated protein kinase kinase 3
2.1 Metallothionein 1H
2.0 Lipopolysaccharide-induced TNF factor
1.4 Interleukin 6 (interferon, beta 2)
Table 2c
Differentially expressed genes involved in cellular structure and cell communication
Clone ID Symbol 10 h 20 h Gene name
249606 RAB9P40 1.4a 2.2 Rab9 effector p40
2177110 LOC388524 1.1 2.2 Similar to Laminin receptor 1
197888 GNB2L1 1.0 2.2 Guanine nucleotide binding protein. beta polypeptide 2-like 1
2028912 WASL 1.0 2.1 Wiskott –Aldrich syndrome-like
2305985 GAL 1.3 2.0 Galanin
755145 VIL2 1.3 2.0 Villin 2 (ezrin)
85313 CCPG1 1.4 2.0 Phosphatidylinositol glycan, class B
52076 OLFM1 1.3 2.0 Olfactomedin 1
505203 TMOD3 1.2 2.1 Tropomodulin 3 (ubiquitous)
713145 CD44 1.2 2.1 CD44 antigen
173674 NPTX1 1.2 2.1 Neuronal pentraxin I
810131 KRT19 1.0 2.2 Keratin 19
774071 PICALM 1.3 2.2 Phosphatidylinositol binding clathrin assembly protein
241530 EPHA2 1.2 2.2 EPH receptor A2
788256 KIF23 1.3 2.3 Kinesin family member 23
110467 CAV2 1.4 2.4 Caveolin 2
664975 CLDN1 1.6 2.4 Claudin 1
970613 RAD21 1.2 2.5 RAD21 homolog (S. pombe)
51582 LMO7 1.6 2.6 LIM domain 7
814546 PSCD1 1.9 2.9 Pleckstrin homology, Sec7 and coiled-coil domains 1
502682 PDLIM7 1.5 2.9 PDZ and LIM domain 7 (enigma)
340558 ARPC5 1.2 3.5 Actin-related protein 2/3 complex, subunit 5, 16 kDa
810512 THBS1 2.6 6.6 Thrombospondin 1
378488 CYR61 1.7 8.4 Cysteine-rich, angiogenic inducer, 61
840567 TM4SF1 3.5 18.8 Transmembrane 4 superfamily member 1
a As described in Table 1.
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at the plasma membrane. The tyrosine kinase receptor EPHA2
determines cell malignancies partly by activating the focal
adhesion kinase, and TM4SF1 is a tumor-associated integrin-
binding transmembrane protein. Finally, genes involved in cell-
to-cell communications and structure, such as the tight junction
component CLDN1 and the cell surface adhesive glycoproteins
CYR61, CD44 and THBS1, were downregulated. Reduced
expression of a number of genes encoding structural compo-
nents involved in intracellular transport was also observed:
KIF23 functions as molecular motors for the movements of
organelles, microtubules or chromosomes along microtubules;
CCPG1 is a major component of the transverse filaments of
synaptonemal complexes; PICALM is a phosphatidylinositol-
binding clathrin assembly protein; CAV2 is a major component
of the inner surface of the caveolae that mediates endocytosis;
and PSCD1 mediates the regulation of protein sorting and
membrane trafficking. Taken together, downregulation of these
genes might contribute to the disintegration of cell structure
and organization observed during the late phase of a virus
infection.
Selective upregulation of genes involved in metabolism and
macromolecular synthesis
Although the majority of deregulated genes demonstrated a
reduced accumulation of RNA during the course of infection,
expression of several genes linked to macromolecular bioge-
nesis was found enhanced (Table 2d). Among genes involved
in the DNA replication were three histones (HIST1H2BJ,
HIST1H2BK and HIST1H2BL), the uracil–DNA glycosylaseUNG and the DNA replication complex factor Pfs2.
Components of the RNA metabolic processes included a
kinase (CLK) regulating phosphorylation of serine/arginine-
rich (SR) proteins required for pre-mRNA splicing, as well as
the SR protein SFRS1 (Colwill et al., 1996). Five ribosomal
proteins, RPL18, RPL35, RPL15, RPL7A and RPS10, were
increased more than 1.8-fold (data not shown), but only
RPS10 showed more than 2-fold change. Several genes
involved in posttranslational processes, such as protein-
folding, were also identified including two heat shock
proteins, HSPA1B and HSPA1L, the hsp90- and hsp70-
associated protein FKBP and the molecular chaperone CCT7.
It should be noted that 50% of the genes classified as
involved in metabolism were upregulated, which is striking
contrast to the predominant repression of genes within the
categories listed in Tables 2a–2c.
Confirmation of microarray result by quantitative real-time
PCR (QRT-PCR)
To confirm the DNA microarray results, QRT-PCR
analyses were performed on a subset of genes. For
comparison, RNA samples from the 6 h infection were
included in the analysis. ACTB was used as normalization
factor. The result for five genes, JUNB, MYC, IL-6, MYBL2
and CYR61, confirmed the array data, although the magni-
tude of regulation was generally higher in the QRT-PCR
compared to the microarray result (Table 3). QRT-PCR was
also performed on the WASL gene, which was the only
upregulated gene involved in actin organization. In contrast to
the microarray results, QRT-PCR analysis of WASL expres-
Table 2d
Differentially expressed genes involved in cellular metabolism and macromolecular synthesis
Clone ID Symbol 10 h 20 h Name
859858 STAR 1.1a 16.4 Steroidogenic acute regulator
290841 HIST1H2BK 1.2 4.1 Histone 1, H2bk
2492634 HSPA1B 4.1 3.6 Heat shock 70 kDa protein 1B
50615 HSPA1L 4.7 3.5 Heat shock 70 kDa protein 1-like
1675553 HIST1H2BJ 1.1 2.6 Histone 1, H2bj
49464 UNG 1.6 2.3 Uracil–DNA glycosylase
2252417 RPS10 1.1 2.2 Ribosomal protein S10
882484 CCT7 1.2 2.2 Chaperonin containing TCP1, subunit 7 (eta)
884799 CACYBP 1.2 2.2 Calcyclin binding protein
1576468 HSD17B2 1.5 2.2 Hydroxysteroid (17-beta) dehydrogenase 2
281039 FABP5 1.3 2.2 Fatty acid binding protein 5 (psoriasis-associated)
2056049 HIST1H2BL 1.1 2.1 Histone 1, H2bl
1600239 Pfs2 1.3 2.1 DNA replication complex GINS protein PSF2
80399 SFRS1 1.4 2.1 Splicing factor, arginine/serine-rich 1 (splicing factor 2)
1570663 FKBP4 1.5 2.1 FK506 binding protein 4, 59 kDa
712916 PSMC3 1.1 2.1 Proteasome (prosome, macropain) 26S subunit, ATPase, 3
1416782 CKB 1.4 2.1 Creatine kinase, brain
2543376 PGC 1.3 2.1 Progastricsin (pepsinogen C)
813459 GTF2E1 1.2 2.0 General transcription factor IIE, polypeptide 1, alpha 56 kDa
205049 HSPB8 1.2 2.0 Heat shock 22 kDa protein 8
2449395 AKR1C2 1.5 2.0 Aldo-keto reductase family 1, member C2
207358 SLC2A1 1.3 2.0 Solute carrier family 2 (facilitated glucose transporter), member 1
485849 CLK1 1.3 2.1 CDC-like kinase 1
361639 GCLM 1.0 2.1 Glutamate-cysteine ligase, modifier subunit
83605 CPS1 1.4 2.2 Carbamoyl-phosphate synthetase 1, mitochondrial
2572290 SQSTM1 1.3 2.3 Sequestosome 1
705274 DGKD 1.6 2.3 Diacylglycerol kinase, delta 130 kDa
813187 DDAH1 1.5 2.3 Dimethylarginine dimethylaminohydrolase 1
34795 DAZAP2 1.6 2.6 DAZ-associated protein 2
48404 GDA 1.2 2.6 Guanine deaminase
288896 KCNK1 1.6 2.7 Potassium channel, subfamily K, member 1
196992 AKR1C1 1.6 2.9 Aldo-keto reductase family 1, member C1
1473304 AKR1C3 1.5 2.9 Aldo-keto reductase family 1, member C3
252515 KYNU 1.5 3.4 Kynureninase (l-kynurenine hydrolase)
897733 SLC38A2 2.0 5.3 Solute carrier family 38, member 2
789376 TXNRD1 1.9 7.7 Thioredoxin reductase 1
a As described in Table 1.
F. Granberg et al. / Virology 343 (2005) 236–245 241sion demonstrated a clear repression, thus concurring with the
general repression of genes involved in cell structure
disintegration.
Discussion
In a previous study, we demonstrated that adenovirus had a
limited effect on the expression of host cell genes during the
early phase of infection in HeLa cells. Here, we show that the
number of target genes, as well as the magnitude of regulation,Table 3
Confirmation of microarray results by QRT-PCR
Symbol Name
JunB junB proto-oncogene
CYR61 Cysteine-rich, angiogenic inducer, 61
MYC V-myc myelocytomatosis viral oncogene homolog (avian)
IL-6 Interleukin 6
MYBL2 V-myb myeloblastosis viral oncogene homolog (avian)-like 2
WASL Wiskott –Aldrich syndrome-like
a As described in Table 1.was increased as the infectious cycle proceeded into the late
phase. Even so, the number of genes still constituted a fraction
(approximately 5%) of detectably expressed genes, indicating
that adenovirus only targets a specific set of cellular genes.
Although it may seem significant that adenovirus targeting of,
for example, genes involved in immune response and antivirus
defense was solely manifested by downregulation, whereas half
of the targeted genes related to macromolecular biogenesis was
upregulated, expression of the majority of host cell genes was
left untouched.QRT-PCR Microarray
6 h p.i. 10 h p.i. 20 h p.i. 10 h p.i. 20 h p.i.
1.5a 1.3 21.40 1.2 2.5
1.2 1.5 46.6 1.7 8.4
1.5 2.6 23.6 1.9 7.4
3.4 3.2 32.7 2.0 1.4
1.1 1.3 2.9 1.3 2.2
1.3 1.2 3.0 1.0 2.1
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additional strategies to redirect the cellular synthesis machinery
to virus production only; the E1B-55 kDa/E4-34 kDa complex
mediates a preferential export of viral mRNA, and the L4-100
kDa protein selectively inhibits translation of cellular mRNA.
The use of several strategies to ensure optimal synthesis of
viral products is likely to be relevant during the non-optimized
conditions of infection in natural host organisms. Whereas the
majority of cellular target genes were upregulated at 6 h post-
infection, the regulation during the late phase primarily caused
a decline in gene expression. A limited number of genes were,
however, upregulated at 20 h post-infection. Most of these
genes appeared refractory to export inhibition of cellular
mRNA since upregulation was also observed in the cytoplas-
mic fraction (Zhao et al., unpublished observation). This
supports the hypothesis that mRNA export is authorized by
transcriptional activation during the late phase (Yang et al.,
1996). It remains to be determined whether these mRNAs
continue to be translated even when accumulation of L4-100 K
has displaced the eIF4E kinase from the cap-initiation complex
eIF4F (Cuesta et al., 2000).
A gradual switch from upregulation to downregulation was
observed during the 6 to 20 h post-infection interval. Several
mechanisms where viral DNA replication provides the break
point might account for this altered pattern of regulation. (i)
During the transit from early to late phase, the viral DNA
replication results in a dramatic increase in transcription-
competent templates that are able to compete for the cellular
transcription machinery and titrate cellular repressors (Iftode
and Flint, 2004). (ii) The activation of a late specific viral
transcription pattern may also affect the utilization of cellular
promoters. (iii) Expression of proteins from the major late
transcription unit has been implicated in regulation of viral gene
expression and turning off expression of cellular genes. (iv)
Inhibition of cellular mRNA transport may result in decreased
accumulation due to altered RNA stability. (v) The immediate
early gene E1A preferentially encodes the 289R major
transcriptional activator during the early phase. As the infection
proceeds into the late phase, a shift in splice selection results in
an increased accumulation of the shorter E1A-243R protein
(Chow et al., 1979). Although E1A-243R retains its capacity to
bind pRb, thereby releasing E2F (Dyson et al., 1992), this
smaller variant of E1A mainly functions as a transcriptional
repressor through its capacity to bind the transcriptional
integrator p300/CBP (Jones, 1995). Since p300/CBP functions
as a coactivator for numerous transcription factors, it is possible
that the ability of E1A to sequester p300/CBP contributes to the
downregulation of cellular genes observed during the late phase
of infection. (vi) Finally, it is also possible that the upregulation
of cellular genes during the early phase, such as the transcription
factors JUNB, NR4A1 and ZNF503, may affect downstream
targets at later stages of infection.
Regulating expression of genes required for S-phase entry is
one of the major events during the early phase of adenovirus
infection. The over-representation of putative E2F binding sites
in adenovirus-induced host cell genes at 6 h post-infection is
consistent with the ability of E1A to interact with pRb, therebyreleasing E2F (Zhao et al., 2003). After efficient replication of
the viral genome has been obtained, regulation of E2F-
dependent genes may no longer be of prime importance. This
might be exemplified by the upregulated expression of the cell
cycle regulating phosphatase CDC25A specifically during the
early phase. During the late phase, it is likely that more efforts
are made to inhibit cellular attempts to halt growth and induce
apoptosis. E1A has previously been shown to block growth
inhibition enforced by TGF-h signaling pathway (de Groot et
al., 1995), and, at 6 h post-infection, we observed an
upregulation of SMURF1, a TGF-h signal terminator, which
triggers the degradation of SMAD1 and 5 (Zhao et al., 2003).
During the late phase of infection, expression of several TGF-h
inducible genes was reduced, including JUNB, ID3, MYC,
KLF10, TGFB1I4, TGFB1I1, IL-6, LMO7, SGK and CTGF.
Of these genes, JUNB, ID3, KLF10, KLF4 and TGFB1I4 have
been described as transcriptional repressors that block cellular
proliferation (Chen et al., 2002). TGFB1I1 and CTGF are both
lost during tumor progression (Martinerie et al., 1992;
Shibanuma et al., 1994). Consistent with the inhibition of the
TGF-h signaling pathway, we also found that expression of
AATF, a target for TGF-h repression (Lindfors et al., 2000),
was upregulated during the late phase. Through interacting
with pRb, AATF may, together with E1A, play an important
role in releasing the pRb inhibition of E2F (Cobrinik, 1996;
Fanciulli et al., 2000). Targeting of the TGF-h is unlikely to be
the only way to avoid growth repression since several TGF-h-
independent growth-arrest-inducing genes, such as GAS1,
TOB1, ARHE and DUSP1, were also repressed (Alessi et al.,
1993; Del Sal et al., 1992; Matsuda et al., 1996; Villalonga et
al., 2004).
Expression of SSB was downregulated during the early time
(Table 1) but gradually increased following the progression
into the late phase of infection. SSB encodes the La
autoantigen that has been shown to stabilize histone mRNA
(McLaren et al., 1997). It remains to be determined whether the
increased levels of mRNA for three histone 2B genes
(HIST1H2BJ, HIST1H2BK and HIST1H2BL) is caused by
an SSB-dependent increase in half-life. In addition, it is also
possible that the upregulation of SSB is required to maximize
the accumulation of adenoviral mRNA. The La protein also has
a positive effect on the translation of mRNAs characterized by
a 5Voligopyrimidine sequence (5V-TOP) (Crosio et al., 2000).
Genes encoding ribosomal proteins are TOP genes, and we
found that transcripts of six ribosomal proteins, RPL18,
RPL35, RPL15, RPL7A and RPS10, were all upregulated.
Therefore, it is possible that enhancing expression of genes
encoding ribosomal proteins occurs at both transcription and
translation levels.
The last stages of an adenovirus infection are distinguished
by strong morphological reorganization of host cell structure
generally described as the cytopathic effect. Starting already
during the early phase of infection, the integrity of
intermediate filaments is disrupted, and vimentin-like filament
collapses into the perinuclear region. Late in the infection,
keratins, such as keratin18, are also cleaved by viral protease
(Chen et al., 1993). In addition to proteolysis, our data
F. Granberg et al. / Virology 343 (2005) 236–245 243demonstrated a decreased accumulation of RNA from genes
involved in cell architecture. Downregulation was seen in
genes involved in actin and intermediate filaments organiza-
tion, communication between actin and the plasma membrane,
intercellular contacts and cell adhesion triggered signals.
Destruction of the cell integrity most likely makes the
infected cell more susceptible to lysis and apt to release
progeny virus. In addition, disruption of cell–cell adhesion
and tight junctions might allow the virus to spread directly
between cells deeper into the infected tissue, thereby evading
circulating inflammatory cells.
In a previous report, we have analyzed regulation of gene
expression in HeLa cells during infection with the oncogenic
adenovirus type 12 (ad12) (Dorn et al., 2005). A lytic ad12
infection takes twice the time, is less productive and causes
reduced cytopathic effect compared to an ad2 infection (23
and reference therein). Overall, more genes were found to be
regulated during the ad2 infection (79 cellular genes showed
more than 1.5-fold regulation during the course of ad12
infection compared to 382 genes showing more than 1.5-fold
change from 10 to 20 h post-infection with ad2). Still, over
55% of the genes identified from the analysis of the ad12
infection were shown to be differentially expressed also in
ad2-infected cells. Genes involved in immune response, cell
cycle/proliferation and metabolism were main targets for both
viruses. However, a few clear differences were found. Most
TGF-h-inducible genes, as well as genes involved in the
TGF-h signaling pathway, were only identified in ad2-
infected cells. Although it is possible that some of the
differences might be the result of the lower number of genes
found to be regulated during an ad12 infection, it is tempting
to speculate that the observed differences constitute the basis
for the different growth characteristics of ad12 and ad2.
Finally, the splicing factor SFRS1 was upregulated in ad2-
infected cells but downregulated in ad12-infected cells.
SFRS1 is required for adenovirus RNA splicing by enhancing
the selection of a proximal 5Vsplice site in E1A mRNA during
the early phase. However, during the late phase, the SFRS1
protein is dephosphorylated which allows altered splice site
selection (Gattoni et al., 1991; Himmelspach et al., 1995).
Although upregulation of SFRS1 seems contra-productive
from the splicing perspective, recent data indicate that
unphosphorylated SFRS1 promotes export of spliced mRNA
(Huang et al., 2004). Notably, the late infected cell nucleus is
loaded with viral mRNA to be exported. Alternative splicing
in ad12 is essentially unexplored, and it also remains to be
investigated whether the ad12 have developed specific export
mechanisms.
Materials and methods
Cell culture, virus infection and RNA isolation
HeLa cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% newborn calf serum
(NCS), 100 U/ml penicillin and 100 Ag/ml streptomycin.
Subconfluent cells were mock-infected or infected withadenovirus type 2 at a multiplicity of 100 fluorescence-forming
units per cell (Philipson, 1961) in a serum-free DMEM. After
45 min of adsorption at 37 -C, the medium was replaced with
DMEM containing 10% NCS. At 10 and 20 h after infection,
total cellular RNA was extracted using TRIZOL Reagent
(Invitrogene). Total RNA was prepared from two independent
adenovirus and mock infections of HeLa cells, respectively.
The quantity and quality of RNA were determined using the
RNA 6000 Nano LabChip Kit and a Bioanalyzer 400 (Agilent
Technologies).
Preparation of cDNA probe and microarray hybridization
Microarrays containing 7500 duplicate-printed human
cDNAs (Human Sequence Verified Set from Research Genetics
Huntsville, AL, USA) were obtained from the DNA Micro-
array Core Facility, Uppsala University, Sweden. In order to
monitor the progression of infection, adenovirus early genes
E1A, E1B, E2A, E3 and E4 and late gene L1 and L3 were also
printed on this array (Zhao et al., 2003). Ten micrograms of
total RNA from adenovirus- and mock-infected cells was used
for generating biotin-labeled cDNA, which was then coupled
with either Cy5 or Cy3, respectively, and hybridized to the
cDNA microarray according to the manufacturer’s post-
labeling protocol (GE Health Care). To control for dye biases,
duplicate reactions were carried out where the fluorescent dyes
were switched during the coupling reaction (so called ‘‘dye-
swap’’ labeled). Thus, a total of 8 experiments were performed,
4 arrays for 10 h and 4 arrays for 20 h RNA samples.
Data analysis
Data collection and normalization were done as described
before (Zhao et al., 2003). Briefly, spot intensity was quantified
using the GenePix Pro 5.1 software. The data, including
corresponding images, were stored in the BASE database at the
Linnaeus Centre for Bioinformatics (LCB), Uppsala University
(Saal et al., 2002). Data handling and print-tip intensity-
dependent normalization (Yang et al., 2002) was performed for
each experiment within the framework of LCBs Dataware-
house. Differentially expressed genes in adenovirus-infected
cells, as compared to mock-infected cells, were identified by
employing cut-off criteria of average-fold value larger than 2
and a coefficient of variation (CV) less than 50% in any of the
two time points.
Quantitative real-time PCR (QRT-PCR)
To verify the results obtained by the microarray experiment,
the QRT-PCR analyses were performed on the same sets of
RNA samples used for microarray hybridization. PCR primers
and Taqman MGB probes for the following genes were
purchased from Applied Biosystems: MYC, JUNB, ACTB,
MYBL2, WASL and CYR62. For cDNA synthesis, 2 Ag of
RNA was reverse-transcribed using Omscript (Qiagen). Real-
time PCR was performed as described previously (Zhao et al.,
2003).
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